Company Filing History:
Years Active: 2015
Title: Raffael Lahav: Innovator in Stable Benzimidazole Formulations
Introduction
Raffael Lahav is a notable inventor based in Qiriat Bialik, Israel. He has made significant contributions to the field of pharmaceutical formulations, particularly with his innovative approach to benzimidazole derivatives.
Latest Patents
Raffael Lahav holds a patent for a stable benzimidazole formulation. This formulation features a stable composition with a benzimidazole derivative, such as Omeprazole, which does not require a separating layer between the active compound and the enteric coating layer. Instead, the enteric coating layer is applied as a solution with a pH value of at least 6.5, preferably ranging from about 7 to about 10, directly onto the benzimidazole derivative substrate. This method allows for the direct coating of the substrate without the need for an intermediate layer. Additionally, the enteric coating can be applied in an aqueous solution, eliminating the necessity for organic solvents. This innovative formulation maintains the stability of the benzimidazole derivative during storage while protecting the product in the acidic environment of the stomach. The interaction between the enteric coat and the alkaline core is completely resolved, as the enteric coat is no longer acidic at this stage.
Career Highlights
Raffael Lahav has dedicated his career to advancing pharmaceutical technologies. His work has led to the development of formulations that enhance the stability and efficacy of medications, particularly those involving benzimidazole derivatives.
Collaborations
Raffael collaborates with Valerie Azoulay, contributing to the innovative projects at Dexcel Ltd. Their partnership has been instrumental in driving forward the research and development of new pharmaceutical formulations.
Conclusion
Raffael Lahav's contributions to the field of pharmaceutical formulations, particularly through his patent for a stable benzimidazole formulation, highlight his innovative spirit and dedication to improving medication stability and efficacy. His work continues to influence the pharmaceutical industry positively.